To assess the validity of ADRB2 expression as a prognostic factor for ccRCC, we assessed Uno’s C-index from time-dependent AUC analysis and AUC at five years for receiver operating characteristics (ROCs) in TCGA and ICGC cohorts (Figure 4). The gene discussed is ADRB2; the disease is nonpapillary renal cell carcinoma.